This project represents the first assessment of Oral Medication (OM) adherence in patients with AML.
CareviveDecember 15, 2021
Note: This on-demand video is not available for CME/CNE credit. Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy…
CareviveJuly 25, 2018
